The anti-tumor mechanism of (-)-epigallocatechin-3-gallate

Journal of International Oncology ›› 2012, Vol. 39 ›› Issue (4): 255-259.

Previous Articles Next Articles

The anti-tumor mechanism of (-)-epigallocatechin-3-gallate

HE Li, TANG Xu-Dong

Department of Biochemistry and Molecular Biology, Guangdong Medical College, Zhanjiang 524023, China

Online:2012-04-08 Published:2012-03-28
Contact: Corresponding author: TANG Xu-dong, E-mail: tangxudong2599@126.com E-mail:tangxudong2599@126.com

Abstract

Abstract: (-)-Epigallocatechin-3-gallate (EGCG), a natural medicine with anti-neoplastic activity, significantly prevent cancers via inhibiting tumor cell proliferation, suppressing angiogenesis and promoting apoptosis, etc. Furthermore, the new discoveries about anti-tumor mechanisms of EGCG in digestive system, reproductive system and respiratory system shorten the course of EGCG application in clinical.

Key words: line-height: 150%">Neoplasms, Cell proliferation, Angiogenesis, Apoptosis, EGCG

HE Li, TANG Xu-Dong. The anti-tumor mechanism of (-)-epigallocatechin-3-gallate[J]. Journal of International Oncology, 2012, 39(4): 255-259.

[1]	Liu Xiaodi, Su Jianfei, Zhang Jingxian, Wei Xueqin, Jia Yingjie. Research progress of myeloid-derived suppressor cells in tumor angiogenesis [J]. Journal of International Oncology, 2024, 51(1): 50-54.
[2]	Pan Shulan, Liu Chang, He Ping. Effect of fritinib on angiogenesis, tumor growth and IRE1-ASK1-JNK pathway in triple negative breast cancer [J]. Journal of International Oncology, 2023, 50(8): 457-462.
[3]	Zhang Yuan, Bai Zhiyu, Li Qi, Feng Qinmei. Current status of research on exosomes in malignancies [J]. Journal of International Oncology, 2023, 50(8): 484-488.
[4]	Zheng Jing, Yao Sheng, Shen Wenjie, Sun Zhijia, Zhao Hui, Fu Yan, Gao Ke, Du Nan. Clinical study of intraperitoneal infusion of bevacizumab combined with albumin paclitaxel and carboplatin in carcinomatous peritoneal adhesion from ovarian cancer [J]. Journal of International Oncology, 2021, 48(11): 660-665.
[5]	Qi Ruili, Wang Huaqing. Research progress of tumor vascular targeting drugs combined with PD-1/PD-L1 antibody in the treatment of digestive system tumors [J]. Journal of International Oncology, 2019, 46(12): 750-754.
[6]	Ke Bin, Li Bin, Liang Han. Research advances of EDIL3 in tumor [J]. Journal of International Oncology, 2019, 46(11): 678-681.
[7]	Feng Yue, Yu Jingping, Wang Jianlin. Application of antiangiogenesis therapy in the radiotherapy of esophageal cancer [J]. Journal of International Oncology, 2017, 44(6): 468-.
[8]	WANG Mei, JIANG Xiao-Dong. The role of epigenetics on antiangiogenesis therapy [J]. Journal of International Oncology, 2017, 44(5): 380-382.
[9]	Hou Xiaoyun, Chu Yanjun.. The mechanism of RNA interference for hepatocellular carcinoma treatment [J]. Journal of International Oncology, 2017, 44(4): 297-299.
[10]	FAN Ze-Ying, ZHANG Xiao-Dong, CHEN Hong-Qing. The mechanism of itraconazole as an anticancer agent [J]. Journal of International Oncology, 2017, 44(2): 136-138.
[11]	Qu Liyan, Kang Xiaoyan, Song Xia. Appliation of the combination of antiangiogenic agents and EGFR-TKIs in advanced NSCLC treatment [J]. Journal of International Oncology, 2017, 44(1): 57-59.
[12]	SUN Ning-Bo, WANG Wei, ZHU Qiang, CAO Ming, JIANG Zhong-Min, ZANG Qi. Inhibitory effect of dexamethasone on residual Lewis lung cancer cells in mice after palliative surgery [J]. Journal of International Oncology, 2016, 43(2): 81-.
[13]	SHANG Yi-Tai, LI Xiao-Jiang. Progress on antiangiogenesis treating head and neck squamous cell carcinoma [J]. Journal of International Oncology, 2015, 42(8): 619-621.
[14]	Zhang Yuemeng, Sun Shanshan, Liu Wenzhi, Gao Wencang. Expression and effect of related factors of lymphangiogenesis in colorectal cancer [J]. Journal of International Oncology, 2015, 42(7): 542-544.
[15]	WU Zheng-Qi-；Zhang-Zhi-Yi-；Wang-Hui-Juan-；Liu-Xiao-Jun. Research progress of three antiangiogenic agents in the treatment of advanced colorectal cancer [J]. Journal of International Oncology, 2015, 42(4): 301-304.

The anti-tumor mechanism of (-)-epigallocatechin-3-gallate

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments